etoposide has been researched along with dexniguldipine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Egle, A; Grunicke, H; Hofmann, J; Ueberall, F | 1 |
| Boer, R; Ferry, DR; Gekeler, V; Ise, W; Kerr, DJ; Malkhandi, J | 1 |
3 other study(ies) available for etoposide and dexniguldipine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance.
Topics: Actins; Animals; Antineoplastic Agents; Calcium Channel Blockers; Carcinoma 256, Walker; Cell Division; Cell Line; Dihydropyridines; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; HeLa Cells; Humans; KB Cells; Mammary Neoplasms, Experimental; Molecular Structure; Rats | 1991 |
Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
Topics: Allosteric Regulation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cell Division; Cyclosporine; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Mathematics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tritium; Tumor Cells, Cultured; Vinblastine; Vincristine | 1994 |